Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 158   

Articles published

NVS 80.11 -0.03 (-0.04%)
price chart
Can Novartis' Entresto be the New Blockbuster?
Novartis AG (NYSE:NVS) announced that its cardiology drug Entresto (sacubitril/valsartan) has finally got an approval under the new guidelines for the management of heart failure and its allied ailments.
Novartis, Amgen to See Higher Sales of New Heart Drugs  Bidness ETC
Can Novartis AG (ADR) Reach Financial Stability via Restructuring?
As Novartis AG (ADR) (NYSE:NVS) head of pharmaceuticals, David Epstein, announced his departure from the company, it initiated the process of restructuring the business portfolios.
Novartis AG (ADR) Gaps Up; Strong Momentum for Buyers
The stock of Novartis AG (ADR) (NYSE:NVS) gapped up by $0.35 today and has $118.23 target or 56.00% above today's $75.79 share price.
Novartis AG (ADR) (NYSE:NVS) To Pay $25 Million Over Bribery Allegations
Last year GlaxoSmithKline plc (ADR) (NYSE:GSK) posted a 17% drop in sales as a state-led campaign on drug prices affected returns.
How Many Novartis AG (ADR) (NYSE:NVS)'s Analysts Are Bullish?
Out of 4 analysts covering Novartis Ag (NYSE:NVS), 0 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means NaN are positive.
HC Stocks Reports Analysis: Nanosphere, Inc. (NASDAQ:NSPH), Novartis AG (ADR ...  share market updates (press release)
Stocks Going Up: Novartis AG (ADR)(NYSE:NVS), Monsanto Company(NYSE:MON)  NYSE Journal (press release)
Primecap Management Company Increased Novartis Ag Adr (NYSE:NVS) by $12.29 ...
Primecap Management Company increased its stake in Novartis Ag Adr (NYSE:NVS) by 0.82% based on its latest 2016Q1 regulatory filing with the SEC.
Novartis AG (ADR) (NYSE:NVS)'S Reputation Takes Another Hit With Fresh Bribery ...
It is emerging that Novartis AG (ADR) (NYSE:NVS) used bribes to juice sales in Turkey between 2013 and 2014. The fresh bribery allegations only increase the spotlight on the drug company that is already battling a string of corrupt practice claims.
Novartis AG (NVS) Rating Lowered to Neutral at Citigroup Inc.  South Florida Hedge Fund Managers
Novartis Is Under SEC Investigation, Probes Reporter Says  Benzinga
Novartis AG (ADR) First-Quarter Earnings: What to Expect?
Novartis AG (ADR) (NYSE:NVS) is set to announce its financial results for the first quarter of 2016 (1Q) on Thursday, April 21.
Attention Grabbing Stocks of Healthcare: CIGNA Corporation (NYSE:CI), Novartis ...
Shares of CIGNA Corporation (NYSE:CI) fell -2.04% to $132.18 at 12:51 PM EDT. The stock attained the volume of 1.24 Million shares recently versus average trading volume of 1.29 Million shares.
Earnings per Share Report: Novartis AG (ADR) (NYSE:NVS)  News Oracle
Novartis AG (ADR) (NYSE:NVS): Big Market Mover
[Market Realist] Novartis AG (ADR) (NYSE:NVS)(TREND ANALYSIS) reported a rise of ~1% in its revenue on a constant currency basis in its 1Q16 earnings.